Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis

Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis

Abstract Background Conventional treatments, including surgery, radiotherapy and chemotherapy, have many limitations in the prognosis of glioma patients. Atorvastatin (ATOR) has a significant inhibitory effect on glioma malignancy. Thus, ATOR may play a key role in the search for new drugs for the e...

Full description

Saved in:
Bibliographic Details
Main Authors: Kang Gao, Tao Zhou, YingChun Yin, XiaoJie Sun, HePing Jiang, TangYue Li
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Hereditas
Subjects:
Glioma
Atorvastatin
miR-125a-5p
TXLNA
Glycolysis
Immune escape
Online Access:https://doi.org/10.1186/s41065-024-00349-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items